CompletedNot applicableNCT01404910

Removal of Anti-Angiogenic Proteins in Preeclampsia Before Delivery

Studying Preeclampsia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Massachusetts General Hospital
Principal Investigator
Ravi I Thadhani, MD, MPH
Massachusetts General Hospital
Intervention
Apheresis using Liposorber LA-15 System(device)
Enrollment
11 enrolled
Eligibility
18-45 years · FEMALE
Timeline
2013 – 2015

Study locations (3)

Collaborators

Kaneka Medical America LLC

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01404910 on ClinicalTrials.gov

Other trials for Preeclampsia

Additional recruiting or active studies for the same condition.

See all trials for Preeclampsia →

← Back to all trials